Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Health Catalyst Announces Agreement to Acquire Twistle

  • Twistle, a Patient Engagement SaaS Technology Solution, to Enhance Health Catalyst’s Population Health Offering and Enable More Comprehensive Support for Organizations Transitioning to Population Health Care Models

Health Catalyst, Inc., a leading provider of data and analytics technology and services to healthcare organizations, announced that it has entered into a definitive agreement to acquire Twistle, Inc. (“Twistle”), an Albuquerque, New Mexico-based healthcare patient engagement SaaS technology company that automates patient-centered, HIPAA-compliant communication between care teams and patients to transform the patient experience, drive better care outcomes, and reduce healthcare costs.

We anticipate that Twistle’s leading clinical workflow and patient engagement platform, paired with the Health Catalyst population health offering, will enable a comprehensive go-to-market solution to address the population health needs of healthcare organizations, as well as Life Science organizations, around the globe. Health Catalyst’s cloud-based data platform, DOS™, will enhance Twistle’s automation by enabling richer data-driven patient interaction. The Twistle technology also enables Health Catalyst’s clinical, quality, and Life Sciences solutions, through established clinical pathways and patient communication channels.

Recommended AI News: Etherlite Is Giving ETL Tokens to Every ETH Wallet Holder; Biggest Airdrop Ever

Related Posts
1 of 19,946

“Twistle is a leading healthcare technology company committed to developing software that healthcare organizations and Life Science companies need to keep patients engaged in their healthcare,” said Dan Burton, CEO of Health Catalyst. “Their efforts to improve patient outcomes and reduce the cost of care are deeply aligned with our mission to be the catalyst for massive, measurable, data-informed improvements. We’re excited to welcome the Twistle team to Health Catalyst and look forward to working together to enable healthcare organizations to achieve the promise of population health.”

“Health Catalyst’s acquisition of Twistle highlights our belief that the most promising technology in healthcare is combining AI and data with ‘digital endpoints’ for patient services to deliver value. Twistle creates endpoints that, in our experience, make it simple for us to interact asynchronously with patients in smarter ways, meeting them where they are digitally, and give our care teams the time to be even better at what they do best—delivering great care,” said Aaron Martin, managing general partner of Providence Ventures and chief digital officer of Providence. “Combined with Health Catalyst’s data and analytics technology, we expect accelerated innovation in personalizing our outreach to patients,” he added.

“The synergy between our cultures, values, and solutions will have a tremendous impact on the health and wellness of patients. Health Catalyst’s patient insights can trigger personalized outreach, and the patient’s unique profile will allow Twistle’s communication pathways to adapt to their preferences and attributes in unprecedented ways. We are excited about the prospects of our joint solutions proactively engaging at-risk populations, advancing health equity, and improving patient activation in their care,” said Kulmeet Singh, founder and CEO of Twistle. “We anticipate that care teams will realize even more efficiency gains as our automated outreach will be more intelligent and individualized, freeing their time to focus on patients that require intervention to stay on track with their medical plan of care.”

Health Catalyst expects to fund the transaction using a mix of stock and cash. The parties expect the transaction, which is subject to customary closing conditions, to close in early Q3 2021. Further details regarding the acquisition will be reported on a Form 8-K filing that will be filed with the Securities and Exchange Commission today.

Recommended AI News: Loopback Analytics Surpasses 30 Clients On The Loopback Platform

Comments are closed.